NAFLD in type 1 diabetes: overrated or underappreciated?
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in western countries, affecting 25–30% of the general population and up to 65% in those with obesity and/or type 2 diabetes. Accumulation of visceral adipose tissue and insulin resistance (IR) contributes to NAFLD. NAF...
Guardado en:
Autores principales: | Jonathan Mertens, Luc F. Van Gaal, Sven M. Francque, Christophe De Block |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/309a074d7b7f4f34b4d8166ab91feff0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Maturity-Onset Diabetes of Young Type 5: Diabetes with Extrapancreatic Features
por: Adnan Haider, et al.
Publicado: (2021) -
Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetes
por: Peter Rossing, et al.
Publicado: (2021) -
Residual C-peptide secretion and hypoglycemia awareness in people with type 1 diabetes
por: Giesje Nefs, et al.
Publicado: (2021) -
Plasma protein N-glycosylation is associated with cardiovascular disease, nephropathy, and retinopathy in type 2 diabetes
por: Femke Rutters, et al.
Publicado: (2021) -
The Effect of Liraglutide on Epicardial Adipose Tissue in Type 2 Diabetes
por: Na Zhao, et al.
Publicado: (2021)